Cargando…

Survival Trends in Patients with Small Intestinal Neuroendocrine Tumours—A Cohort Study in Central Norway

SIMPLE SUMMARY: Neuroendocrine tumours in the small intestine (SI-NETs) may be cured with surgery, and oncological treatment may prolong survival. The trend in survival may improve over time due to advances in surgical or oncological treatment or if the disease is diagnosed at an earlier stage. We e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Folkestad, Oddry, Hauso, Øyvind, Mjønes, Patricia, Fougner, Reidun, Wasmuth, Hans H., Fossmark, Reidar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339968/ https://www.ncbi.nlm.nih.gov/pubmed/37444383 http://dx.doi.org/10.3390/cancers15133272

Ejemplares similares

Survival and Disease Recurrence in Patients with Duodenal Neuroendocrine Tumours—A Single Centre Cohort
por: Folkestad, Oddry, et al.
Publicado: (2021)

Do Gastric Signet Ring Cell Carcinomas and ECL-Cell Neuroendocrine Tumours Have a Common Origin?
por: Fossmark, Reidar, et al.
Publicado: (2022)

Laser lithotripsy for the treatment of a giant fecalith obstructing a colorectal anastomosis
por: Fossmark, Reidar, et al.
Publicado: (2023)

Animal Models to Study the Role of Long-Term Hypergastrinemia in Gastric Carcinogenesis
por: Fossmark, Reidar, et al.
Publicado: (2011)

Not only stem cells, but also mature cells, particularly neuroendocrine cells, may develop into tumours: time for a paradigm shift
por: Waldum, Helge L., et al.
Publicado: (2018)

Gastric Cancers Missed at Upper Endoscopy in Central Norway 2007 to 2016—A Population-Based Study
por: Beck, Marianne, et al.
Publicado: (2021)

Gastric Corpus Mucosal Hyperplasia and Neuroendocrine Cell Hyperplasia, but not Spasmolytic Polypeptide-Expressing Metaplasia, Is Prevented by a Gastrin Receptor Antagonist in H(+)/K(+)ATPase Beta Subunit Knockout Mice
por: Aasarød, Kristin Matre, et al.
Publicado: (2020)

Expression of the Cholecystokinin-B Receptor in Neoplastic Gastric Cells
por: Mjønes, Patricia, et al.
Publicado: (2017)

Survival in Patients with Neuroendocrine Tumours of the Small Intestine: Nomogram Validation and Predictors of Survival
por: Levy, Sonja, et al.
Publicado: (2020)

Classification of tumours
por: Waldum, Helge L, et al.
Publicado: (2008)

How do nursing home doctors involve patients and next of kin in end-of-life decisions? A qualitative study from Norway
por: Romøren, Maria, et al.
Publicado: (2016)

Lack of informed consent for surgical procedures by elderly patients with inability to consent: a retrospective chart review from an academic medical center in Norway
por: Dahlberg, Jorgen, et al.
Publicado: (2019)

Hypergastrinemia is associated with an increased risk of gastric adenocarcinoma with proximal location: A prospective population‐based nested case‐control study
por: Ness‐Jensen, Eivind, et al.
Publicado: (2020)

Incidence and Survival of Patients with Small Intestinal Neuroendocrine Tumours in a Danish NET Center
por: Hoej, Lise Brehm, et al.
Publicado: (2012)

Gastritis, Gastric Polyps and Gastric Cancer
por: Waldum, Helge, et al.
Publicado: (2021)

Reply to “Too Soon to Dismiss Inflammation-Related Differences in the Mucosa-Associated Microbiota in Crohn’s Disease Patients”
por: Olaisen, Maya, et al.
Publicado: (2022)

Inflammation and Digestive Cancer
por: Waldum, Helge, et al.
Publicado: (2023)

Melatonin Immunoreactivity in Malignant Small Intestinal Neuroendocrine Tumours
por: Söderquist, Fanny, et al.
Publicado: (2016)

Molecular prognostic factors in small-intestinal neuroendocrine tumours
por: Samsom, K G, et al.
Publicado: (2019)

Evolution of the Mesenteric Mass in Small Intestinal Neuroendocrine Tumours
por: Blažević, Anela, et al.
Publicado: (2021)

Intestinal staphylococcal small colony variants: a cause of medically unexplained physical symptoms?
por: Berstad, Arnold, et al.
Publicado: (2014)

Proton pump inhibitors and gastric cancer: a long expected side effect finally reported also in man
por: Waldum, Helge Lyder, et al.
Publicado: (2018)

Types of Gastric Carcinomas
por: Waldum, Helge L., et al.
Publicado: (2018)

Role of Autoimmune Gastritis in Gastric Cancer
por: Waldum, Helge L., et al.
Publicado: (2019)

Impact on continuity of care of decentralized versus partly centralized mental health care in Northern Norway
por: Myklebust, Lars Henrik, et al.
Publicado: (2011)

Time-trends in the utilization of decentralized mental health services in Norway - A natural experiment: The VELO-project
por: Myklebust, Lars H, et al.
Publicado: (2010)

Time to Classify Tumours of the Stomach and the Kidneys According to Cell of Origin
por: Waldum, Helge, et al.
Publicado: (2021)

Correct Identification of Cell of Origin May Explain Many Aspects of Cancer: The Role of Neuroendocrine Cells as Exemplified from the Stomach
por: Waldum, Helge, et al.
Publicado: (2020)

Factors associated with the persistence of oral 5-aminosalicylic acid monotherapy in ulcerative colitis: a nationwide Norwegian cohort study
por: Fossmark, Reidar, et al.
Publicado: (2021)

The central role of gastrin in gastric cancer
por: Waldum, Helge, et al.
Publicado: (2023)

Non-functional pancreatic neuroendocrine tumours: emerging trends in incidence and mortality
por: Wu, Junjun, et al.
Publicado: (2019)

Prognostic factors for death after surgery for small intestinal neuroendocrine tumours
por: Eriksson, J., et al.
Publicado: (2018)

Study protocol for a multicenter investigation of reablement in Norway
por: Langland, Eva, et al.
Publicado: (2015)

Nomogram for individually predicting overall survival in rectal neuroendocrine tumours
por: Feng, Xingyu, et al.
Publicado: (2020)

Is empiric proton pump inhibition in patients with symptoms of extraesophageal gastroesophageal reflux justified?
por: Fossmark, Reidar, et al.
Publicado: (2023)

A multicenter investigation of reablement in Norway: a clinical controlled trial
por: Langeland, E., et al.
Publicado: (2019)

Erratum to: Study protocol for a multicenter investigation of reablement in Norway
por: Langeland, Eva, et al.
Publicado: (2015)

Anti-tumour effects of lanreotide for pancreatic and intestinal neuroendocrine tumours: the CLARINET open-label extension study
por: Caplin, Martyn E, et al.
Publicado: (2016)

Chromosome 18 Loss of Heterozygosity in Small Intestinal Neuroendocrine Tumours: Multi-Omic and Tumour Composition Analyses
por: Waterfield, Scott, et al.
Publicado: (2023)

Adverse Effects of Proton Pump Inhibitors—Evidence and Plausibility
por: Fossmark, Reidar, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_h286ol3dqb9aa73g2s72ed5ovj